Coagulopathy in elderly patients with coronavirus disease 2019

14Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Since the outbreak of coronavirus disease 2019 (COVID-19), clinical features have been analyzed in detail. However, coagulopathy in elderly COVID-19 patients has been scarcely reported. Methods: Coagulation parameters of 189 patients with COVID-19 in Tongji hospital were retrospectively analyzed among age groups. Results: Patients were divided into 2 groups: older group (≥65 years, n = 87) and younger group (<65 years, n = 102). The proportion of patients with elevated fibrinogen (79.0% vs 59.6%, p =.005) and D-dimer (78.0% vs 55.2%, p =.001) shows the significant difference between the groups. The elderly patients revealed significantly longer prothrombin time (14.0 [13.4–14.4]s vs 13.6 [13.2–14.1]s, p =.026), higher D-dimer (1.00 [0.5–1.9] μg/mL vs 0.6 [0.3–1.6] μg/mL, p =.013) and fibrinogen (5.2 [4.1–6.2] g/L vs 4.4 [3.4–5.7] g/L, p =.004) levels, compared to the younger group. A positive correlation was observed between the coagulation parameters and inflammatory markers including high-sensitivity C-reactive protein and interleukin-6 (p

Cite

CITATION STYLE

APA

Yuan, X., Tong, X., Wang, Y., Wang, H., Wang, L., & Xu, X. (2020). Coagulopathy in elderly patients with coronavirus disease 2019. Aging Medicine, 3(4), 260–265. https://doi.org/10.1002/agm2.12133

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free